New drug could be a breakthrough in treatment for killer TB, trial suggests
PositiveScience

- Sorfequiline has demonstrated stronger efficacy than current TB treatments, indicating a significant advancement in the fight against this deadly disease. This breakthrough could lead to improved patient outcomes and a reduction in TB
- The implications of this development are profound, as it may enhance global health efforts to combat tuberculosis, which remains a major public health challenge, particularly in high
— via World Pulse Now AI Editorial System

